Media Inquiries
- 615-322-6397 Email
Latest Stories
- Sean Davies awarded Scaling Success grant to develop small molecules with promise of protecting against cardiometabolic disease
- Vanderbilt biochemists contribute to breakthrough discovery of first new antibacterial class in decades
- WATCH: 5 sustainability efforts you may not know about at Vanderbilt (Part Two)
Ray Stevens, the Provost Professor of Chemistry and Molecular Biology at the University of Southern California, presents the inaugural Stanley Cohen Lecture Friday, March 4, from noon to 1 p.m. in Light Hall, Room 214.
Stevens’ lecture, “Understanding the Complete GPCR Superfamily,” is part of the Frontiers in Biochemistry Seminar Series. The lecture is sponsored by the Department of Biochemistry and co-sponsored by the Vanderbilt Institute of Chemical Biology.
Stevens is founding director of the Bridge Institute at USC and holds joint appointments in the Viterbi School of Engineering and Keck School of Medicine. He pioneered the area of high throughput structural biology—essential work for understanding the human body at atomic resolution as well as critical for pharmaceutical drug development. He has helped develop several therapeutic molecules that have become breakthrough drugs to treat conditions ranging from rare childhood diseases to neuromuscular disorders and diabetes, and has authored more than 330 peer-reviewed publications in the area of human cell signaling. He holds a series of patents, and his laboratory has launched four biotech startups.
D. Borden Lacy, associate professor of pathology, microbiology and immunology and associate professor of biochemistry, is host for the event.
Contact: Jen Smith, (615) 322-3318